- Home
- Companies
- Novo Nordisk Pharmatech A/S
- Products
- NovoNordisk - Recombinant Insulin
NovoNordisk - Recombinant Insulin
Recombinant Insulin (also known as Insulin Human AF) is a recombinant protein consisting of human insulin crystals, a biosynthetic product created using recombinant microbial expression in yeast. As insulin binds to its receptor, it initiates intracellular signalling pathways that regulate cell growth, differentiation, survival and glucose uptake. This promotes cell culture growth and enhances protein yields by modulating transcription, DNA synthesis and replication, and stimulating protein translocation. Recombinant Insulin is used to produce monoclonal antibodies, virus vaccines, gene therapy drugs, and other innovative biologic products approved for use by regulatory bodies worldwide.
- High purity, recombinant, animal-free product
- Batch-to-batch consistency
- Reliable and experienced partner, with +100 years experience in insulin
- Secure improved cell growth and protein yield
- Following global regulatory compliance
Our Recombinant Insulin is a key component in serum free growth media for mammalian cells. It is used as supplement in the cell culture media for several cell lines, such as CHO, HEK293 or Sf9, for the manufacturing of monoclonal antibodies, virus vaccines, or gene therapy products.
High-performance biomanufacturing processes are needed to accelerate the time-to-market of safe and efficient drugs, reaching thousands of patients worldwide. The unique biological properties of insulin make it a key growth-supporting ingredient in many different cell culture processes. Recombinant Insulin improves cell proliferation and boosts the production of therapeutic proteins for various applications, viral vectors for advanced therapies, and viruses for vaccines.
From monoclonal antibodies to cell and gene therapies, and vaccines, Novo Nordisk Pharmatech’s Recombinant Insulin is contributing to improving the lives of people living with arthritis, cancer, multiple sclerosis, and many other medical conditions.
Explore the many applications and learn how Recombinant Insulin can help support your formulations.